I specialize clinically in: GU Malignancies (Prostate, Bladder and Testicular cancers) and Sarcomas.
Dr. Pollack’s research interests have centered on the management of prostate cancer with radiotherapy (RT), with and without androgen deprivation therapy (ADT).
Dr. Pollack's research interests center on the therapeutic management of prostate cancer, with an emphasis on applying biomarkers, including quantitative imaging, tissue genomic, and liquid biopsy markers, to identify prostate characteristics that determine outcome.